Page History
...
Pre Interview:
Item | Information/Response |
---|---|
Date: | 12/09/2009 |
Requirement # unique id <SemCon Ops Initiative>.<analysts initials><requirement number> | Init1dbw1 |
Originator/Customer's Name: | CBIIT - Margaret Haber |
Originator/Customer's Company: | Genzyme |
Stakeholder Community:
| Health care and biomedical research related industry, such as pharmaceutical and medical equipment manufacturers |
Summary of requirement pre-interview, by Reviewer: | We are working on use cases and requirements for new semantic infrastructure and would be willing to share when they are available in the fall timeframe |
Recommended Next Step Enter one: Follow-up interview, Observe, Use Case Template (text), Use Case Model (formalized/UML diagram), Group Discussion, Prototype, Waiting Room | Review attachements and develop follow up plan - complete interview/questions below |
Post Interview - ongoing throughout development of use cases:
Item | Description | Information/Response |
---|---|---|
Requirement Type (required) | Analyst's assessment of the most appropriate category/type of requirement (no need to ask interviewee):
| --- |
ConOp Initiative(s) |
| --- |
Use Case Linkage (required) | Which use case(s) is this requirement linked to? (should follow Use Case numbering scheme <SemCon Ops Initiative>.<analysts initials><requirement number>.<use case number>, for example Init1dbw1.1, Init1dbw1.2, Init2dbw2.1, 2.2, etc. | Use case Number(s): |
Conflicts / Dependencies(required) | Are there any conflicts with other requirements / use cases? | Yes OR No - If yes, what and why? |
Next Step (required) | After reviewing the results of the interview, the forum, and all other materials related to this requirement, the analyst should recommend the next step, then attach the Tiny Link (on the Info tab) for this page to the Master List table. | Enter one: Follow-up interview, Observe, Use Case Template (text), Use Case Model (formalized/UML diagram), Group Discussion, Prototype, Waiting Room |
Scrollbar | ||
---|---|---|
|